マーケットレポート詳細
マイクロカテーテルの世界市場：2028年に至る製品別、用途別予測
Microcatheters Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年 7月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文225ページになります。
- 商品コード：MAM3332
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
マイクロカテーテルの世界市場規模は2023年の8億7,400万ドルから、2028年までに11億4,200万ドルへと拡大し、予測期間の市場の平均年成長率は5.5%で推移することが見込まれています。
レポートはマイクロカテーテルの世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、製品デザイン別市場、等）を中心に構成されています。また競合状況、主要企業情報（17社）、市場ダイナミクス、業界構造分析などの分析も加味し、マイクロカテーテル市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆マイクロカテーテルの世界市場予測2020-2028年
・市場規模(US$)
◆製品別、市場-2028年
・デリバリーマイクロカテーテル
・アスピレーションマイクロカテーテル
・診断用マイクロカテーテル
・可動型マイクロカテーテル
※(市場規模US$)
◆製品デザイン別、市場-2028年
・シングルルーメンマイクロカテーテル
・デュアル/マルチルーメンマイクロカテーテル
※(市場規模US$)
◆用途別、市場-2028年
・心臓血管
・神経血管
・末梢血管
・泌尿器
・腫瘍
・耳鼻咽喉科
・その他用途
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・病院、外科センター、専門クリニック
・外来診療センター
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
中東アフリカ
※地域別に全セグメント別の細分化データ掲載、詳細は目次参照
※国別に製品別の細分化データ掲載
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・主要なステークホルダーと購買基準
・業界構造分析（ファイブフォース分析）
・規制分析
・価格分析
・バリューチェーン分析
・サプライチェーン分析
・特許分析
・ケーススタディ分析
・競合状況
◆マイクロカテーテルの主要企業プロフィール動向
・MEDTRONIC
・BOSTON SCIENTIFIC CORPORATION
・TERUMO MEDICAL CORPORATION
・TELEFLEX INCORPORATED
・MERIT MEDICAL SYSTEMS, INC.
・朝日インテック株式会社
・STRYKER
・SURMODICS, INC.
・CARDINAL HEALTH, INC.
・JOHNSON & JOHNSON
・GUERBET LLC
・LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
・BECTON, DICKINSON AND COMPANY
・PENUMBRA, INC.
・株式会社カネカ
・ANGIODYNAMICS, INC.
・BIOCARDIA INC.
（その他企業）
・MILLAR, INC.
・BAYLIS MEDICAL COMPANY, INC.
・EMBOLX, INC.
・ACANDIS GMBH
・ACROSTAK
・COOK MEDICAL
・REFLOW MEDICAL, INC.
・TZ MEDICAL, INC.
・ORBUSNEICH MEDICAL
・SPARTAN MICRO, INC.
・TRANSIT SCIENTIFIC
・株式会社東海メディカルプロダクツ
・リバテープ製薬株式会社
（全225頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED 26
1.3.2 REGIONS COVERED 26
1.3.3 INCLUSIONS AND EXCLUSIONS
1.3.4 YEARS CONSIDERED 27
1.4 CURRENCY CONSIDERED
1.5 RESEARCH LIMITATIONS
1.6 MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 RESEARCH DESIGN: MICROCATHETERS MARKET
・ FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
・ FIGURE 3 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 PRIMARY SOURCES
2.1.2.2 KEY INDUSTRY INSIGHTS
2.1.2.3 BREAKDOWN OF PRIMARIES
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
・ FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
・ FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
・ FIGURE 7 MICROCATHETERS MARKET: COMPANY REVENUE ESTIMATION APPROACH
2.2.1.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION APPROACH
・ FIGURE 8 MICROCATHETERS MARKET: CUSTOMER-BASED MARKET SIZE ESTIMATION APPROACH
2.2.1.3 APPROACH 3: TOP-DOWN APPROACH
・ FIGURE 9 MICROCATHETERS MARKET: TOP-DOWN APPROACH
2.2.1.4 APPROACH 4: PRIMARY INTERVIEWS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 GROWTH RATE ASSUMPTIONS
2.7 RISK ASSESSMENT
・ TABLE 1 MICROCATHETERS MARKET: RISK ASSESSMENT
3 EXECUTIVE SUMMARY
・ FIGURE 11 MICROCATHETERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 MICROCATHETERS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2023 VS. 2028 (USD MILLION)
・ FIGURE 14 MICROCATHETERS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 15 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET
4 PREMIUM INSIGHTS
4.1 MICROCATHETERS MARKET OVERVIEW
・ FIGURE 16 INCREASING GERIATRIC POPULATION AND GROWING R&D INVESTMENTS
BY GOVERNMENT TO DRIVE MARKET
4.2 MICROCATHETERS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 17 DELIVERY MICROCATHETERS TO DOMINATE MICROCATHETERS
MARKET IN 2028
4.3 MICROCATHETERS MARKET, BY REGION AND END USER, 2022 (USD MILLION)
・ FIGURE 18 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS SEGMENT DOMINATED MICROCATHETERS MARKET IN 2022
4.4 GEOGRAPHICAL SNAPSHOT OF MICROCATHETERS MARKET
・ FIGURE 19 INDIA TO BE FASTEST GROWING COUNTRY IN GLOBAL MICROCATHETERS MARKET DURING STUDY PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 20 MICROCATHETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 RISING TARGET PATIENT POPULATION SUFFERING FROM CHRONIC DISEASES GLOBALLY
・ FIGURE 21 NUMBER OF NEW CANCER CASES (GLOBAL), BY CANCER SITE (2018 VS. 2020)
5.2.1.2 ADVANCEMENTS IN MICROCATHETER TECHNOLOGIES
5.2.1.3 INCREASE IN GOVERNMENT INITIATIVES, HEALTHCARE FUNDING, AND HEALTH-RELATED SERVICES
・ TABLE 2 NATIONAL AVERAGE MEDICARE REIMBURSEMENT CPT CODES, 2022
5.2.1.4 INCREASED PREFERENCE FOR MINIMALLY INVASIVE SURGERIES OVER TRADITIONAL OPEN SURGERIES
5.2.2 RESTRAINTS
5.2.2.1 STRINGENT REGULATORY GUIDELINES IN MATURE MARKETS
5.2.2.2 HIGH COST OF MICROCATHETERS AND BUDGET CONSTRAINTS IN HEALTHCARE FACILITIES
5.2.3 OPPORTUNITIES
5.2.3.1 EXPANSION OF KEY PLAYERS IN EMERGING ECONOMIES
5.2.3.2 RISING HEALTHCARE EXPENDITURE ACROSS EMERGING ECONOMIES
・ FIGURE 22 GOVERNMENT HEALTH EXPENDITURE (% OF GDP)
・ FIGURE 23 GOVERNMENT HEALTH EXPENDITURE [AS % OF GENERAL GOVERNMENT EXPENDITURE]
5.2.4 CHALLENGES
5.2.4.1 AVAILABILITY OF ALTERNATIVE TECHNOLOGIES FOR CATHETERIZATION
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROCATHETERS MARKET
・ TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCT SEGMENTS (%)
5.4 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 4 MICROCATHETERS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF SUPPLIERS
5.4.4 BARGAINING POWER OF BUYERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
5.5 REGULATORY ANALYSIS
5.5.1 US
・ TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.5.2 EUROPE
5.5.3 JAPAN
・ TABLE 6 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.6 PRICING ANALYSIS
・ TABLE 7 PRICING ANALYSIS: MICROCATHETERS MARKET, 2023 (USD)
5.7 REIMBURSEMENT SCENARIO ANALYSIS
・ TABLE 8 CPT CODES FOR MAJOR MICROCATHETERS
5.8 ECOSYSTEM MAPPING
5.9 VALUE CHAIN ANALYSIS
5.9.1 RESEARCH & DEVELOPMENT
5.9.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.9.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
・ FIGURE 25 VALUE CHAIN ANALYSIS: MICROCATHETERS MARKET
5.10 SUPPLY CHAIN ANALYSIS
5.10.1 PROMINENT COMPANIES
5.10.2 SMALL & MEDIUM-SIZED COMPANIES
5.10.3 END USERS
・ FIGURE 26 SUPPLY CHAIN ANALYSIS: MICROCATHETERS MARKET
5.11 PATENT ANALYSIS
・ TABLE 9 IMPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND)
・ TABLE 10 EXPORT DATA FOR MICROCATHETERS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND)
5.12 TECHNOLOGY ANALYSIS
5.13 CASE STUDY ANALYSIS
・ TABLE 11 CASE STUDY: EMBOLIZATION FOR CHEST WALL HEMORRHAGE-DIREXION MICROCATHETER STORY
5.14 KEY CONFERENCES AND EVENTS IN 2023–2024
・ TABLE 12 DETAILED LIST OF KEY CONFERENCES AND EVENTS IN 2023–2024
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
・ FIGURE 27 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
5.16 IMPACT OF ECONOMIC RECESSION ON MICROCATHETERS MARKET
6 MICROCATHETERS MARKET, BY PRODUCT
6.1 INTRODUCTION
・ TABLE 13 MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
・ TABLE 14 MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
・ TABLE 15 MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION)
・ TABLE 16 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
6.2 DELIVERY MICROCATHETERS
6.2.1 INCREASING NUMBER OF TARGET INTERVENTIONAL PROCEDURES TO DRIVE MARKET
・ TABLE 17 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION)
・ TABLE 18 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
・ TABLE 19 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION)
・ TABLE 20 MICROCATHETERS MARKET FOR DELIVERY MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION)
6.3 ASPIRATION MICROCATHETERS
6.3.1 GROWING BURDEN OF CARDIOVASCULAR DISEASES AND RELATED MEDICAL CONDITIONS TO DRIVE MARKET 78
・ TABLE 21 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY REGION, 2020–2028 (USD MILLION)
・ TABLE 22 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
・ TABLE 23 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 79
・ TABLE 24 MICROCATHETERS MARKET FOR ASPIRATION MICROCATHETERS,
BY END USER, 2020–2028 (USD MILLION)
6.4 DIAGNOSTICS MICROCATHETERS
6.4.1 LARGE TARGET PATIENT POPULATION FOR VASCULAR DISEASES TO DRIVE MARKET
・ TABLE 25 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION)
・ TABLE 26 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
・ TABLE 27 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION) 81
・ TABLE 28 MICROCATHETERS MARKET FOR DIAGNOSTIC MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION)
6.5 STEERABLE MICROCATHETERS
6.5.1 GROWING NUMBER OF IMAGE-GUIDED AND MINIMALLY INVASIVE MEDICAL PROCEDURES TO DRIVE MARKET
・ TABLE 29 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION)
・ TABLE 30 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
・ TABLE 31 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY APPLICATION, 2020–2028 (USD MILLION)
・ TABLE 32 MICROCATHETERS MARKET FOR STEERABLE MICROCATHETERS, BY END USER, 2020–2028 (USD MILLION)
7 MICROCATHETERS MARKET, BY PRODUCT DESIGN
7.1 INTRODUCTION
・ TABLE 33 MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
7.2 SINGLE-LUMEN MICROCATHETERS
7.2.1 INCREASING NUMBER OF TARGET MEDICAL PROCEDURES AND OPERATIONAL ADVANTAGES TO DRIVE MARKET
・ TABLE 34 MICROCATHETERS MARKET FOR SINGLE-LUMEN MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION)
7.3 DUAL AND MULTI-LUMEN MICROCATHETERS
7.3.1 IMPROVED SURGICAL PRECISION AND INCREASED ADOPTION IN COMPLEX VASCULAR PROCEDURES TO DRIVE MARKET
・ TABLE 35 MICROCATHETERS MARKET FOR DUAL AND MULTI-LUMEN MICROCATHETERS, BY REGION, 2020–2028 (USD MILLION)
8 MICROCATHETERS MARKET, BY APPLICATION
8.1 INTRODUCTION
・ TABLE 36 MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
8.2 CARDIOVASCULAR APPLICATIONS
8.2.1 EFFECTIVE DEVICE PLACEMENT DURING MINIMALLY INVASIVE PROCEDURES AND CRITICAL CARDIAC SURGERIES TO DRIVE MARKET
・ TABLE 37 MICROCATHETERS MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION)
8.3 NEUROVASCULAR APPLICATIONS
8.3.1 INCREASING INCIDENCE OF TARGET NEUROLOGICAL CONDITIONS TO DRIVE MARKET
・ TABLE 38 MICROCATHETERS MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION)
8.4 PERIPHERAL VASCULAR APPLICATIONS
8.4.1 RISING NUMBER OF DIAGNOSTIC AND INTERVENTIONAL PROCEDURES TO DRIVE MARKET
・ TABLE 39 MICROCATHETERS MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2020–2028 (USD MILLION)
8.5 UROLOGY APPLICATIONS
8.5.1 INCREASING PREVALENCE OF UROLOGICAL DISORDERS AND ADVANCEMENTS IN MINIMALLY INVASIVE TECHNIQUES TO DRIVE MARKET
・ TABLE 40 MICROCATHETERS MARKET FOR UROLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION)
8.6 ONCOLOGY APPLICATIONS
8.6.1 INCREASING CLINICAL RESEARCH ON MINIMALLY INVASIVE CANCER TREATMENT TO DRIVE MARKET
・ TABLE 41 MICROCATHETERS MARKET FOR ONCOLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION)
8.7 OTOLARYNGOLOGY APPLICATIONS
8.7.1 INCREASED NEED FOR DELICATE ACCESS AND PRECISE NAVIGATION IN DIAGNOSIS TO DRIVE MARKET
・ TABLE 42 MICROCATHETERS MARKET FOR OTOLARYNGOLOGY APPLICATIONS, BY REGION, 2020–2028 (USD MILLION)
8.8 OTHER APPLICATIONS
・ TABLE 43 MICROCATHETERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2028 (USD MILLION)
9 MICROCATHETERS MARKET, BY END USER
9.1 INTRODUCTION
・ TABLE 44 MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION)
9.2 HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS
9.2.1 LARGE NUMBER OF SURGICAL AND DIAGNOSTIC PROCEDURES TO DRIVE MARKET
・ TABLE 45 MICROCATHETERS MARKET FOR HOSPITALS, SURGICAL CENTERS, AND SPECIALTY CLINICS, BY REGION, 2020–2028 (USD MILLION)
9.3 AMBULATORY CARE CENTERS
9.3.1 GROWING PATIENT SUBMISSIONS FOR DIAGNOSTIC PROCEDURES IN EMERGING ECONOMIES TO DRIVE MARKET
・ TABLE 46 MICROCATHETERS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2020–2028 (USD MILLION)
10 MICROCATHETERS MARKET, BY REGION
10.1 INTRODUCTION
・ TABLE 47 MICROCATHETERS MARKET, BY REGION, 2020–2028 (USD MILLION)
10.2 NORTH AMERICA
・ FIGURE 28 NORTH AMERICA: MICROCATHETERS MARKET SNAPSHOT
10.2.1 RECESSION IMPACT: NORTH AMERICA
・ TABLE 48 NORTH AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
・ TABLE 49 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
・ TABLE 50 NORTH AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
・ TABLE 51 NORTH AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
・ TABLE 52 NORTH AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION)
10.2.2 US
10.2.2.1 US TO DOMINATE NORTH AMERICAN MICROCATHETERS MARKET DURING FORECAST PERIOD
・ TABLE 53 US: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 INCREASING PREVALENCE OF TARGET DISEASES AND HIGH DEMAND FOR TIMELY DIAGNOSIS TO DRIVE MARKET
・ TABLE 54 CANADA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.3 EUROPE
10.4 RECESSION IMPACT: EUROPE
・ TABLE 55 EUROPE: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
・ TABLE 56 EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
・ TABLE 57 EUROPE: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
・ TABLE 58 EUROPE: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
・ TABLE 59 EUROPE: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION)
10.4.1 GERMANY
10.4.1.1 INCREASING AGING POPULATION AND RISING LIFE EXPECTANCY TO DRIVE MARKET
・ TABLE 60 GERMANY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.2 FRANCE
10.4.2.1 SIGNIFICANT EVOLUTION OF HEALTHCARE SECTOR AND GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET
・ TABLE 61 FRANCE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.3 UK
10.4.3.1 HIGH BURDEN OF CHRONIC DISEASES AND LARGE VOLUMES OF SURGERIES TO DRIVE MARKET
・ TABLE 62 UK: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.4 ITALY
10.4.4.1 INCREASING GERIATRIC POPULATION TO DRIVE MARKET
・ TABLE 63 ITALY: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.5 SPAIN
10.4.5.1 INCREASING TECHNOLOGICAL DEVELOPMENTS IN HEALTHCARE SECTOR TO DRIVE MARKET
・ TABLE 64 SPAIN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.4.6 REST OF EUROPE
・ TABLE 65 REST OF EUROPE: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.5 ASIA PACIFIC
10.6 RECESSION IMPACT: ASIA PACIFIC
・ FIGURE 29 ASIA PACIFIC: MICROCATHETERS MARKET SNAPSHOT
・ TABLE 66 ASIA PACIFIC: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
・ TABLE 67 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
・ TABLE 68 ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
・ TABLE 69 ASIA PACIFIC: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
・ TABLE 70 ASIA PACIFIC: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION)
10.6.1 JAPAN
10.6.1.1 INCREASING GERIATRIC POPULATION AND SURGICAL PROCEDURES TO DRIVE MARKET
・ TABLE 71 JAPAN: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.6.2 CHINA
10.6.2.1 GROWING PREVALENCE OF CHRONIC DISORDERS AND DEVELOPING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
・ TABLE 72 CHINA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.6.3 INDIA
10.6.3.1 INCREASING TARGET PATIENT POPULATION WITH RISING AVAILABILITY OF ADVANCED SURGICAL TREATMENTS TO DRIVE MARKET
・ TABLE 73 INDIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.6.4 AUSTRALIA
10.6.4.1 DEVELOPING HEALTHCARE SECTOR AND INCREASING AVAILABILITY OF ADVANCED SURGICAL TREATMENTS TO DRIVE MARKET
・ TABLE 74 AUSTRALIA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.6.5 SOUTH KOREA
10.6.5.1 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET
・ TABLE 75 SOUTH KOREA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.6.6 REST OF ASIA PACIFIC
・ TABLE 76 REST OF ASIA PACIFIC: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.7 LATIN AMERICA
10.8 RECESSION IMPACT: LATIN AMERICA
・ TABLE 77 LATIN AMERICA: MICROCATHETERS MARKET, BY COUNTRY, 2020–2028 (USD MILLION)
・ TABLE 78 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
・ TABLE 79 LATIN AMERICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
・ TABLE 80 LATIN AMERICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
・ TABLE 81 LATIN AMERICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION)
10.8.1 BRAZIL
10.8.1.1 DEVELOPING HEALTHCARE SECTOR AND INCREASING AVAILABILITY OF ADVANCED SURGICAL TREATMENTS TO DRIVE MARKET
・ TABLE 82 BRAZIL: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.8.2 MEXICO
10.8.2.1 FAVORABLE GOVERNMENT INITIATIVES AND RAPIDLY GROWING HEALTHCARE SECTOR TO DRIVE MARKET
・ TABLE 83 MEXICO: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
10.9 MIDDLE EAST & AFRICA
10.9.1 INCREASING FOCUS OF MARKET PLAYERS AND ONGOING ECONOMIC GROWTH TO DRIVE MARKET
10.10 RECESSION IMPACT: MIDDLE EAST & AFRICA
・ TABLE 84 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT, 2020–2028 (USD MILLION)
・ TABLE 85 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY PRODUCT DESIGN, 2020–2028 (USD MILLION)
・ TABLE 86 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY APPLICATION, 2020–2028 (USD MILLION)
・ TABLE 87 MIDDLE EAST & AFRICA: MICROCATHETERS MARKET, BY END USER, 2020–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROCATHETERS MARKET
・ TABLE 88 OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROCATHETERS MARKET
11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
・ FIGURE 30 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN MICROCATHETERS MARKET
11.4 MARKET RANKING ANALYSIS
・ FIGURE 31 MICROCATHETERS MARKET RANKING, BY KEY PLAYER (2022)
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
・ FIGURE 32 MICROCATHETERS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES
・ FIGURE 33 MICROCATHETERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/ SMES, 2022
11.7 COMPANY FOOTPRINT
・ TABLE 89 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN MICROCATHETERS MARKET
・ TABLE 90 COMPANY PRODUCT FOOTPRINT
・ TABLE 91 COMPANY GEOGRAPHICAL FOOTPRINT
11.8 COMPETITIVE SCENARIOS AND TRENDS
・ TABLE 92 KEY PRODUCT LAUNCHES
・ TABLE 93 KEY DEALS
・ TABLE 94 OTHER KEY DEVELOPMENTS
12 COMPANY PROFILES
12.1 KEY PLAYERS 148
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
12.1.1 MEDTRONIC
・ TABLE 95 MEDTRONIC: COMPANY OVERVIEW 148
・ FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT (2022)
12.1.2 BOSTON SCIENTIFIC CORPORATION
・ TABLE 96 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
・ FIGURE 35 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
12.1.3 TERUMO MEDICAL CORPORATION 157
・ TABLE 97 TERUMO MEDICAL CORPORATION: COMPANY OVERVIEW
・ FIGURE 36 TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT (2022)
12.1.4 TELEFLEX INCORPORATED
・ TABLE 98 TELEFLEX INCORPORATED: COMPANY OVERVIEW
・ FIGURE 37 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)
12.1.5 MERIT MEDICAL SYSTEMS, INC. 167
・ TABLE 99 MERIT MEDICAL SYSTEMS, INC.: COMPANY OVERVIEW
・ FIGURE 38 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2022)
12.1.6 ASAHI INTECC CO., LTD.
・ TABLE 100 ASAHI INTECC CO., LTD.: COMPANY OVERVIEW
・ FIGURE 39 ASAHI INTECC CO., LTD.: COMPANY SNAPSHOT (2022)
12.1.7 STRYKER
・ TABLE 101 STRYKER: COMPANY OVERVIEW
・ FIGURE 40 STRYKER: COMPANY SNAPSHOT (2022)
12.1.8 SURMODICS, INC.
・ TABLE 102 SURMODICS, INC.: COMPANY OVERVIEW
・ FIGURE 41 SURMODICS, INC.: COMPANY SNAPSHOT (2022)
12.1.9 CARDINAL HEALTH, INC.
・ TABLE 103 CARDINAL HEALTH, INC.: COMPANY OVERVIEW
・ FIGURE 42 CARDINAL HEALTH, INC.: COMPANY SNAPSHOT (2022)
12.1.10 JOHNSON & JOHNSON
・ TABLE 104 JOHNSON & JOHNSON: COMPANY OVERVIEW
・ FIGURE 43 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022)
12.1.11 GUERBET LLC
・ TABLE 105 GUERBET LLC: COMPANY OVERVIEW
・ FIGURE 44 GUERBET LLC: COMPANY SNAPSHOT (2022)
12.1.12 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD
・ TABLE 106 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY OVERVIEW
・ FIGURE 45 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: COMPANY SNAPSHOT (2022)
12.1.13 BECTON, DICKINSON AND COMPANY
・ TABLE 107 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
・ FIGURE 46 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
12.1.14 PENUMBRA, INC.
・ TABLE 108 PENUMBRA, INC.: COMPANY OVERVIEW
・ FIGURE 47 PENUMBRA, INC.: COMPANY SNAPSHOT (2022)
12.1.15 KANEKA CORPORATION
・ TABLE 109 KANEKA CORPORATION: COMPANY OVERVIEW
・ FIGURE 48 KANEKA CORPORATION: COMPANY SNAPSHOT (2022)
12.1.16 ANGIODYNAMICS, INC.
・ TABLE 110 ANGIODYNAMICS, INC.: COMPANY OVERVIEW
・ FIGURE 49 ANGIODYNAMICS, INC.: COMPANY SNAPSHOT (2022)
12.1.17 BIOCARDIA INC.
・ TABLE 111 BIOCARDIA INC.: COMPANY OVERVIEW
12.2 OTHER PLAYERS
12.2.1 MILLAR, INC.
12.2.2 BAYLIS MEDICAL COMPANY, INC. 209
12.2.3 EMBOLX, INC.
12.2.4 ACANDIS GMBH
12.2.5 ACROSTAK
12.2.6 COOK MEDICAL
12.2.7 REFLOW MEDICAL, INC.
12.2.8 TZ MEDICAL, INC.
12.2.9 ORBUSNEICH MEDICAL
12.2.10 SPARTAN MICRO, INC.
12.2.11 TRANSIT SCIENTIFIC
12.2.12 TOKAI MEDICAL PRODUCTS
12.2.13 LIBATAPE PHARMACEUTICAL CO., LTD
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS